|
1
|
Tsokos GC: Systemic lupus erythematosus. N
Engl J Med. 365:2110–2121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pons-Estel GJ, Alarcon GS, Scofield L,
Reinlib L and Cooper GS: Understanding the epidemiology and
progression of systemic lupus erythematosus. Semin Arthritis Rheum.
39:257–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gregersen PK and Olsson LM: Recent
advances in the genetics of autoimmune disease. Annu Rev Immunol.
27:363–391. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Waldman M and Appel GB: Update on the
treatment of lupus nephritis. Kidney Int. 70:1403–1412. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sprangers B, Monahan M and Appel GB:
Diagnosis and treatment of lupus nephritis flares-an update. Nat
Rev Nephrol. 8:709–717. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kalloo S, Aggarwal N, Mohan P and
Radhakrishnan J: Lupus nephritis: Treatment of resistant disease.
Clin J Am Soc Nephrol. 8:154–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Saxena R, Mahajan T and Mohan C: Lupus
nephritis: Current update. Arthritis Res Ther. 13:2402011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Waldman M and Madaio MP: Pathogenic
autoantibodies in lupus nephritis. Lupus. 14:19–24. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhat P and Radhakrishnan J: B lymphocytes
and lupus nephritis: New insights into pathogenesis and targeted
therapies. Kidney Int. 73:261–268. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kahlenberg JM, Thacker SG, Berthier CC,
Cohen CD, Kretzler M and Kaplan MJ: Inflammasome activation of
IL-18 results in endothelial progenitor cell dysfunction in
systemic lupus erythematosus. J Immunol. 187:6143–6156. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ciferska H, Horak P, Konttinen YT, Krejci
K, Tichy T, Hermanova Z and Zadrazil J: Expression of nucleic acid
binding Toll-like receptors in control, lupus and transplanted
kidneys-a preliminary pilot study. Lupus. 17:580–585. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Yang J, Jiang S, Fang C, Xiong L,
Cheng H and Xia Y: The lupus-derived anti-double-stranded DNA IgG
contributes to myofibroblast-like phenotype in mesangial cells. J
Clin Immunol. 32:1270–1278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Seret G, Le Meur Y, Renaudineau Y and
Youinou P: Mesangial cell-specific antibodies are central to the
pathogenesis of lupus nephritis. Clin Dev Immunol. 2012:5796702012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yung S, Tsang RC, Leung JK and Chan TM:
Increased mesangial cell hyaluronan expression in lupus nephritis
is mediated by anti-DNA antibody-induced IL-1beta. Kidney Int.
69:272–280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jeruc J, Jurcic V, Vizjak A, Hvala A,
Babic N, Kveder R, Praprotnik S and Ferluga D: Tubulo-interstitial
involvement in lupus nephritis with emphasis on pathogenesis. Wien
Klin Wochenschr. 112:702–706. 2000.PubMed/NCBI
|
|
16
|
Fiore N, Castellano G, Blasi A, Capobianco
C, Loverre A, Montinaro V, Netti S, Torres D, Manno C, Grandaliano
G, et al: Immaturemyeloid and plasmacytoid dendritic cells
infiltrate renal tubulointerstitium in patients with lupus
nephritis. Mol Immunol. 45:259–265. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang X, Jin M, Wu H, Nadasdy T, Nadasdy
G, Harris N, Green-Church K, Nagaraja H, Birmingham DJ, Yu CY, et
al: Biomarkers of lupus nephritis determined by serial urine
proteomics. Kidney Int. 74:799–807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mosley K, Tam FW, Edwards RJ, Crozier J,
Pusey CD and Lightstone L: Urinary proteomic profiles distinguish
between active and inactive lupus nephritis. Rheumatology (Oxford).
45:1497–1504. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Perrot M1, Sagliocco F, Mini T, Monribot
C, Schneider U, Shevchenko A, Mann M, Jenö P and Boucherie H:
Two-dimensional gel protein database of Saccharomyces cerevisiae
(update 1999). Electrophoresis. 20:2280–2298. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Patton WF: Detection technologies in
proteome analysis. J Chromatogr B Analyt Technol Biomed Life Sci.
771:3–31. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mok CC and Lau CS: Pathogenesis of
systemic lupus erythematosus. J Clin Pathol. 56:481–490. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weening JJ, D'Agati VD, Schwartz MM,
Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T,
Ferrario F, et al: The classification of glomerulonephritis in
systemic lupus erythematosus revisited. J Am Soc Nephrol.
15:241–250. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stainsby D: Guide to Preparation, Use and
Quality Assurance of Blood Components. Recommendation No. R (95)
15. J Clin Pathol. 51:2010.
|
|
24
|
Wei XF, Zhou QG, Hou FF, Liu BY and Liang
M: Advanced oxidation protein products induce mesangial cell
perturbation through PKC-dependent activation of NADPH oxidase. Am
J Physiol Renal Physiol. 296:F427–F437. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bairoch A and Apweiler R: The SWISS-PROT
protein sequence database and its supplement TrEMBL in 2000.
Nucleic Acids Res. 28:45–48. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao L, Zhou D, Tan RJ, Fu H, Zhou L, Hou
FF and Liu Y: Sustained activation of wnt/β-catenin signaling
drives AKI to CKD progression. J Am Soc Nephrol. 27:1727–1740.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tedeschi SK, Bermas B and Costenbader KH:
Sexual disparities in the incidence and course of SLE and RA. Clin
Immunol. 149:211–218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu YP, Hu SW, Wu ZF, Mei LX, Lang P and
Lu XH: Proteomic analysis of human serum from diabetic retinopathy.
Int J Ophthalmol. 4:616–622. 2011.PubMed/NCBI
|
|
29
|
Siever DA and Erickson HP: Extracellular
Annexin II. Int J Biochem Cell Biol. 29:1219–1223. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim J and Hajjar KA: Annexin II: A
plasminogen-plasminogen activator co-receptor. Front Biosci.
7:d341–d348. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vedeler A, Hollas H, Grindheim AK and
Raddum AM: Multiple roles of Annexin A2 in post-transcriptional
regulation of gene expression. Curr Protein Pept Sci. 13:401–412.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bharadwaj A, Bydoun M, Holloway R and
Waisman D: Annexin A2 heterotetramer: Structure and function. Int J
Mol Sci. 14:6259–6305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng CW, Rifai A, Ka SM, Shui HA, Lin YF,
Lee WH and Chen A: Calcium-binding proteins Annexin A2 and S100A6
are sensors of tubular injury and recovery in acute renal failure.
Kidney Int. 68:2694–2703. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ka SM, Rifai A, Chen JH, Cheng CW, Shui
HA, Lee HS, Lin YF, Hsu LF and Chen A: Glomerular crescent-related
biomarkers in a murine model of chronic graft versus host disease.
Nephrol Dial Transplant. 21:288–298. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yung S, Cheung KF, Zhang Q and Chan TM:
Anti-dsDNA antibodies bind to mesangial Annexin II in lupus
nephritis. J Am Soc Nephrol. 21:1912–1927. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu NQ, De Marchi T, Timmermans Am,
Beekhof R, Trapman-Jansen AM, Foekens R, Look MP, van Deurzen CH,
Span PN, Sweep FC, et al: Ferritin heavy chain in triple negative
breast cancer: A favorable prognostic marker that relates to a
cluster of differentiation 8 positive (CD8+) effector T-cell
response. Mol Cell Proteomics. 13:1814–1827. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang W, Knovich MA, Coffman LG, Torti FM
and Torti SV: Serum ferritin: Past, present and future. Biochim
Biophys Acta. 1800:760–769. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Recalcati S, Invernizzi P, Arosio P and
Cairo G: New functions for an iron storage protein: The role of
ferritin in immunity and autoimmunity. J Autoimmun. 30:84–89. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang KH, Tian HY, Gao X, Lei WW, Hu Y,
Wang DM, Pan XC, Yu ML, Xu GJ, Zhao FK and Song JG: Ferritin heavy
chain-mediated iron homeostasis and subsequent increased reactive
oxygen species production are essential for epithelial-mesenchymal
transition. Cancer Res. 69:5340–5348. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zarjou A, Bolisetty S, Joseph R, Traylor
A, Apostolov EO, Arosio P, Balla J, Verlander J, Darshan D, Kuhn LC
and Agarwal A: Proximal tubule H-ferritin mediates iron trafficking
in acute kidney injury. J Clin Invest. 123:4423–4434. 2013.
View Article : Google Scholar : PubMed/NCBI
|
